ArticleNature communications2024
Stabilized ε-Fe
Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Constructing water-resistant phase-pure alloy carbide for boosting syngas to olefins.Nature communications · 2026Article
- Steering Peroxymonosulfate Activation Toward Exclusive Singlet Oxygen Generation via Active Iron Carbides Nanoparticles.Small (Weinheim an der Bergstrasse, Germany) · 2026Article
- Controlling Exsolution Dynamics in High-Entropy Oxides for Highly Active and Selective Acetylene Semi-Hydrogenation.Angewandte Chemie (International ed. in English) · 2026Article
- Boosting Selectivity toward Long-Chain α‑Olefins in COJACS Au · 2026Article
- Stabilized FeNature communications · 2025Article
- One-Step Low-Temperature Synthesis of Metastable ε-Iron Carbide Nanoparticles with Unique Catalytic Properties Beyond Conventional Iron Catalysts.Small (Weinheim an der Bergstrasse, Germany) · 2025Article
- Potassium-stabilized metastable carbides and chalcogenides via surface chemical potential modulation.Nature communications · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Accurately controlling the product selectivity in syngas conversion, especially increasing the olefin selectivity while minimizing C1 byproducts, remains a significant challenge. Epsilon Fe
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.